Robeco Institutional Asset Management B.V. lifted its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 7.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 85,132 shares of the medical research company’s stock after acquiring an additional 5,668 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Thermo Fisher Scientific were worth $14,851,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of TMO. BB&T Securities LLC raised its holdings in Thermo Fisher Scientific by 4.4% in the first quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock valued at $13,798,000 after acquiring an additional 3,819 shares in the last quarter. State Board of Administration of Florida Retirement System lifted its stake in Thermo Fisher Scientific by 0.9% in the second quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock worth $101,317,000 after acquiring an additional 5,213 shares during the last quarter. Mitchell Capital Management Co. lifted its stake in Thermo Fisher Scientific by 40.3% in the second quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock worth $7,841,000 after acquiring an additional 12,910 shares during the last quarter. Toronto Dominion Bank lifted its stake in Thermo Fisher Scientific by 53.5% in the first quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock worth $16,450,000 after acquiring an additional 37,307 shares during the last quarter. Finally, IBM Retirement Fund lifted its stake in Thermo Fisher Scientific by 117.7% in the second quarter. IBM Retirement Fund now owns 9,537 shares of the medical research company’s stock worth $1,860,000 after acquiring an additional 5,157 shares during the last quarter. 83.36% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have commented on TMO. Jefferies Group LLC reiterated a “hold” rating and set a $195.00 price target on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Goldman Sachs Group, Inc. (The) began coverage on shares of Thermo Fisher Scientific in a report on Tuesday, September 26th. They issued a “buy” rating and a $225.00 price objective on the stock. Barclays PLC reaffirmed an “overweight” rating and set a $215.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Monday, September 25th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 price objective for the company in a research report on Thursday, September 21st. Finally, Cowen and Company reaffirmed an “outperform” rating and set a $220.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. One investment analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $202.21.

In other Thermo Fisher Scientific news, Director Jim P. Manzi sold 11,318 shares of the company’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the sale, the director now owns 38,757 shares in the company, valued at $6,702,635.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Gregory J. Herrema sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $176.02, for a total value of $5,280,600.00. Following the sale, the senior vice president now owns 67,016 shares in the company, valued at approximately $11,796,156.32. The disclosure for this sale can be found here. Insiders have sold 52,738 shares of company stock worth $9,302,112 in the last ninety days. Corporate insiders own 0.49% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/robeco-institutional-asset-management-b-v-buys-5668-shares-of-thermo-fisher-scientific-inc-tmo/1606754.html.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at 190.33 on Wednesday. The stock has a market capitalization of $74.25 billion, a P/E ratio of 33.16 and a beta of 1.05. The stock has a 50 day moving average price of $185.02 and a 200 day moving average price of $173.34. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The company’s revenue was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.03 EPS. On average, equities analysts anticipate that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be given a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.32%. Thermo Fisher Scientific’s payout ratio is 10.45%.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.